Assured Research on Inflation Risks: 1st to 3rd Party (October, 2022)
During September medical inflation reached its highest point since the ACA was passed more than ten years ago. Meanwhile, the baton has steadily been passing from flexible inflation (1st party and property coverages) to sticky inflation (liability components like wages, medical). We have a substantial body of work on this topic (with more on medical inflation in our November Briefing). Contact us for a free trial and access to this content.
Assured Research's Popular P&C 101/201 on Demand (August, 2022)
We have delivered our immensely popular P&C 101 Teach In (Answering: How does this industry work?) to hundreds of professionals; newcomers, young professionals, board members, and veterans looking to expand their understanding of P&C. The 2.5 hour webinar is on demand and can be accessed with a FREE TRIAL. Contact us for more.
Assured Research on Inflation and the Risk of Recession (July, 2022)
In its July Assured Briefing Assured Research tackled a number of questions on the minds of insurance professionals in light of rising inflation and risk of a recession. The industry is recession resistant, but not recession proof is one topic. Another - our industry's pricing power could be adversely impacted by slowing sales and margins across the corporate landscape. Contact us for a free trail and copy of this month's Briefing.
Assured Industry Reserve Study shows $22.3 Bil. Redundancy (March, 2022)
We released our 9th annual study of the industry's loss reserves in mid-March. The two main takeaways: 1) Reserves for workers' compensation remain notably redundant, and 2) Across other lines we are largely in agreement with the industry's selected reserves and ultimate loss ratios. That's good, though it means the onus is on insurers to price accurately for surging inflation. We'd be happy to share our report with those taking a free trial to our work. Contact us.
Assured Industry Study on PFAS - Forever Chemicals (January, 2022)
Why are PFAS called 'Forever Chemicals' we ask in this Assured Industry Study? Because they are going to drive insurance claims forever - or at least for a very long time is our answer. This substantial deep-dive into the topic of PFAS focuses primarily on water contamination and property remediation claims since that is the litigation most active presently. But there will be more, both in our research, and in the form of product liability and CGL claims if PFAS are linked to any 'signature diseases'. We'd be pleased to share the Study with any firm that takes a free trial to our work.